Latest news
Cadrenal Therapeutics (CVKD): PNC discloses 8.13% beneficial stake for client - Stock TitanStock Titan · Fri, 07 Aug 2026 17:04:02 GMTNasdaq, S&P 500, Dow Futures Pause After Strong H1 Rally Ahead Of Payrolls: Why NKE, TSLA, NIO, MU, LUNR, CVKD Are In Focus - StocktwitsStocktwits · Fri, 07 Aug 2026 12:22:08 GMTCVKD | Cadrenal Therapeutics, Inc. Common Executive Compensation - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 00:09:18 GMTCadrenal Therapeutics (CVKD) Slips 2.49% to $1.96 as Shares Test Range-Bound Support - Zigzag Correction - dars.gov.etdars.gov.et · Tue, 04 Aug 2026 02:47:41 GMTCadrenal Therapeutics, Inc. SEC Filing (Aug 3, 2026) - Stock TitanStock Titan · Mon, 03 Aug 2026 21:14:31 GMTCVKD: Positive CAD-1005 Data Accelerates Transition Toward Business Development Strategy - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 16:15:00 GMTCAD-1005 Phase 2 Data Show >25% Absolute Reduction in Thrombotic Events - Stock TitanStock Titan · Mon, 03 Aug 2026 12:30:00 GMTCVKD ARS & SEC Filings - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 07:00:00 GMT